Resources

College student, type 1 diabetes, wears a pump and CGM. She has good family support. Several of her family members get her CGM readings on their phone. She received a call from her mother about 2:45 am waking her up. She told her to treat her low blood glucose, which patient reported to be 41.

In part 3 of this Exclusive Interview about the new diabetes classification, facilitating the individual use of "evidence-based practice" to individually assess the situation of a specific patient, instead of allowing media supposition about a drug class -- such as SGLT-2s -- to dictate diabetes treatment.

In this week's Homerun Slides, ADA guidelines and other special considerations in the treatment of older T2 patients.

Beta-Cell function and glucose homeostasis: Insulin secretion, together with the sensitivity to insulin of glucose-utilizing tissues, is a key player in glucose homeostasis. What is relevant for glucose homeostasis is not the absolute insulin secretion levels but insulin secretion relative to glucose, as typically assessed by the beta-cell dose-response during the physiologic condition of oral glucose ingestion. Thus, beta-cell glucose sensitivity is strongly inversely associated to mean glucose levels during a standard OGTT and explains, together with insulin sensitivity, a substantial proportion of the variability in glucose levels.

Starting patients diagnosed within the last 7 years on 2-4 weeks of intensive insulin therapy could help keep them off additional medications for at least 48 weeks.

Studies suggest fenofibrate can prevent microvascular changes, decrease need for surgery.

Tighter glucose and blood pressure control found to decrease incidence.

A phase 2 randomized controlled trial demonstrated clinically significant changes in glycemic control.

Metformin use has been associated with significant disturbances in acid-base balance.

Influenza vaccination may reduce cardiac-related hospital admissions and all cause mortality in patients with diabetes.